Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This study will evaluate if the combination of Pomalidomide, Cyclophosphamide and Prednisone is safe and provides benefits in patients with multiple myeloma relapsed and/or refractory to lenalidomide.
Epistemonikos ID: 15520d94deb7e8d3028507b048a41a56a449ef55
First added on: May 05, 2024